Tag : APAAACI

Hereditary angioedema (HAE) is a rare, yet potentially life-threatening, inheritable disease characterized by episodic attacks of cutaneous and submucosal swelling. Unfortunately, the adoption and implementation of international guidelines established in Asia-Pacific (AP) populations remains limited due to a lack of expertise, infrastructure, public awareness, and access. In an interview with Omnihealth Practice, Professor Philip Li, Board Director of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and lead author of a recently published epidemiologic study of HAE in the AP region, outlined the regional epidemiologic characteristics of HAE, current challenges and priority areas that require attention to optimize HAE management in the AP region. He also shared insights regarding the most recent Hong Kong-Macau Severe Hives and Angioedema Referral Pathway (SHARP) which offers guidance on patient stratification and referral strategies in patients with urticaria.